Government Briefs

Differing Views On AIDS Funding Scientists who don't receive federal funds to do AIDS research think that the government's AIDS program has drained away research dollars from other fields. But scientists who receive such funds think those other disciplines have not been affected. These findings are part of a survey by the congressional Office of Technology Assessment, sent to 400 members of the Institute of Medicine. The survey was actually conducted to measure the impact of AIDS research on ot

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Differing Views On AIDS Funding Scientists who don't receive federal funds to do AIDS research think that the government's AIDS program has drained away research dollars from other fields. But scientists who receive such funds think those other disciplines have not been affected. These findings are part of a survey by the congressional Office of Technology Assessment, sent to 400 members of the Institute of Medicine. The survey was actually conducted to measure the impact of AIDS research on other fields, and the 142 respondents pointed to major contributions in immunology, virology, molecular biology, and microbiology. But when it came to judging federal spending priorities, OTA confirmed the adage that where you sit is the best indicator of where you stand on a particular issue. Some 73 percent of the scientists who don't get federal funds and don't do AIDS-related research believed that AIDS funding was squeezing other fields, while ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies